Emerging genomic technologies and the concept of personalized medicine.
With the completion of the Human Genome Project in May 2006, genetic testing for every American is rapidly becoming a reality. As the advanced technology fuels the path towards personalized medicine, genetic nondiscrimination legislation follows closely behind. It seems that the 2007 Genetic Information Nondiscrimination Act (GINA) will finally pass through both chambers of Congress and will be signed by the President, but questions remain. On May 1, 2008, the House passed GINA by a vote of 414 to 1. Why is this the year that genetic nondiscrimination legislation could finally become the reality? Is this the beginning of a new relationship between science and policy, where policy is finally catching up? We examine the answers to these questions through a look at the history of genetic nondiscrimination legislation and where it stands today, including arguments for and against the bill. We conclude by discussing how we can achieve a future of safe personalized medicine for the populous, which would require continuous productive interactions between policymakers and scientists.
Glinskii
Victoria G
VG
The School of Public Health, The University of California at Berkeley, Berkeley, California, USA. gglinsky@ordwayresearch.org
Glinsky
Gennadi V
GV
D005820:Genetic Testing / Q000331:legislation & jurisprudence; D023281:Genomics / Q000379:methods* / Q000639:trends*; D006801:Humans; D007206:Individuality; D007883:Legislation, Medical / Q000639:trends; D008511:Medicine / Q000639:trends*; D011287:Prejudice; D014481:United States